Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles by leading authorities describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future.
Gut is an official journal of the British Society of Gastroenterology.
Editor-in-Chief: Professor Emad El-Omar, University of New South Wales, Sydney, Australia
TOP CITED ARTICLES
Read the most-cited articles from the past three years for free here.
Read our latest press-released articles:
Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years
Yogurt consumption and risk of conventional and serrated precursors of colorectal cancer
To cite: Biasci D, Lee JC, Noor NM, et al. Gut 2019;68:1386-1395.
Read the full article here: link
Objective: We have previously described a prognostic transcriptional signature in CD8 T cells that separates patients with IBD into two phenotypically distinct subgroups, termed IBD1 and IBD2. Here we sought to develop a blood-based test that could identify these subgroups without cell separation, and thus be suitable for clinical use in Crohn’s disease (CD) and ulcerative colitis (UC).
Conclusion: This is the first validated prognostic biomarker that can predict prognosis in newly diagnosed patients with IBD and represents a step towards personalised therapy.